Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Summer;2(3):250-2.
doi: 10.1097/ICB.0b013e31816b31d1.

Ranibizumab for choroidal neovascularization in fundus flavimaculatus

Amparo Navea Tejerina  1 , Maria García-Pous, Elena Palacios Pozos, M Carmen Desco Esteban, Jorge Mataix Boronat
Affiliations

Ranibizumab for choroidal neovascularization in fundus flavimaculatus

Amparo Navea Tejerina et al. Retin Cases Brief Rep. 2008 Summer.

Abstract

Purpose: To report the features of a case with late-onset fundus flavimaculatus (FFM) complicated by choroidal neovascularization (CNV) and treated with ranibizumab.

Methods: Retrospective interventional case report.

Patient: A 51-year-old woman presented with right eye decreased vision. Fundus flavimaculatus with CNV was diagnosed by electroretinography and fluorescein angiography.

Results: Two intravitreal injections of ranibizumab were needed for the treatment. At the end of follow-up (9 months) no leakage was observed and visual acuity improved.

Conclusion: Choroidal neovascularization is a rare complication of FFM. Ranibizumab, an anti-VEFG drug, stopped neovascularization and improved final visual acuity in this case, so it must be considered in the treatment of CNV in late onset FFM.

PubMed Disclaimer

LinkOut - more resources